Skip to content

HTEMS Treatment of Diabetic Polyneuropathy

High-tone External Muscle Stimulation for Treatment of Diabetic Polyneuropathy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04593992
Acronym
HTEMS-RCT
Enrollment
80
Registered
2020-10-20
Start date
2020-10-20
Completion date
2021-12-31
Last updated
2022-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Polyneuropathy

Keywords

diabetes, neuropathy, pain, HTEMS

Brief summary

So far, there are no sufficient pharmacologic therapies for the treatment of diabetic neuropathy. Therefore, we evaluated application of high-tone external muscle stimulation (HTEMS) compared to placebo treatment in patients with diabetic neuropathy.

Detailed description

Patients (n=80) with symptomatic diabetic neuropathy will be included into this randomized controlled trial. Each intervention will be administered for a period of at least 30 min on at leat 5 days in a week. Health impairments will be assessed using the neuropathy symptom score (NSS) before, during and after intervention.

Interventions

DEVICEHTEMS

high-tone external muscle stimulation

DEVICEPlacebo

Placebo stimulation

Sponsors

gbo Medizintechnik AG
CollaboratorUNKNOWN
West German Center of Diabetes and Health
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* symptomatic diabetic neuropathy * stable oral analgesic regimen

Exclusion criteria

* history of drug or alcohol abuse * cardiac pacemaker or defibrillator * pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Neuropathy symptom score12 weeksNeuropathic symptoms measured by the neuropathic symptom score (NSS). Range 1-10 with higher scores indicationg a worse outcome.

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026